98%
921
2 minutes
20
In the specialized domain of brain tumor segmentation, supervised segmentation approaches are hindered by the limited availability of high-quality labeled data, a condition arising from data privacy concerns, significant costs, and ethical issues. In response to this challenge, this paper presents a training framework that adeptly integrates a plug-and-play component, MOD, into current supervised learning models, boosting their efficacy in scenarios with limited data. The MOD consists of an Online Tokenizer and a Dense Predictor, which employs self-distillation and self-modeling on masked patches, promoting swift convergence and efficient representation learning. During the inference phase, the plug-and-play MOD component is excluded, preserving the computational efficiency of the original model without incurring extra processing costs. We substantiated the value of our approach through experiments on leading 3D brain tumor segmentation baselines. Remarkably, models augmented with the MOD consistently showcased superior results, achieving elevated Dice coefficients and HD95 scores on two datasets: BraTS 2021 and MSD 2019 Task-01 Brain Tumor. Code: https://github.com/deepang-ai/MOD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/JBHI.2025.3530715 | DOI Listing |
Nat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFEMBO Mol Med
September 2025
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, 100071, Beijing, China.
Traditional live attenuated vaccines (LAVs) are typically developed through serial passaging or genetic engineering to introduce specific mutations or deletions. While viral RNA secondary or tertiary structures have been well-documented for their multiple functions, including binding with specific host proteins, their potential for LAV design remains largely unexplored. Herein, using Zika virus (ZIKV) as a model, we demonstrate that targeted disruption of the primary sequence or tertiary structure of a specific viral RNA element responsible for Musashi-1 (MSI1) binding leads to a tissue-specific attenuation phenotype in multiple animal models.
View Article and Find Full Text PDFJ Hum Genet
September 2025
Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Comprehensive genomic profiling (CGP) expands treatment options for solid tumor patients and identifies hereditary cancers. However, in Japan, confirmatory tests have been conducted in only 31.6% of patients with presumed germline pathogenic variants (GPVs) detected through tumor-only testing.
View Article and Find Full Text PDFExp Neurobiol
August 2025
Institute of Medical Science, Ajou University School of Medicine, Suwon 16499, Korea.
Neural tumors represent diverse malignancies with distinct molecular profiles and present particular challenges due to the blood-brain barrier, heterogeneous molecular etiology including epigenetic dysregulation, and the affected organ's critical nature. KCC-07, a selective and blood-brain barrier penetrable MBD2 (methyl CpG binding domain protein 2) inhibitor, can suppress tumor development by inducing p53 signaling, proven only in medulloblastoma. Here we demonstrate KCC-07 treatment's application to other neural tumors.
View Article and Find Full Text PDFMed Eng Phys
October 2025
Biomedical Device Technology, Istanbul Aydın University, Istanbul, 34093, Istanbul, Turkey. Electronic address:
Deep learning approaches have improved disease diagnosis efficiency. However, AI-based decision systems lack sufficient transparency and interpretability. This study aims to enhance the explainability and training performance of deep learning models using explainable artificial intelligence (XAI) techniques for brain tumor detection.
View Article and Find Full Text PDF